Gemstones are elements of minerals which when polished and cut are used for making jewelry and other ornaments, as well as for decoration purposes.
Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.

In 2021, the global Gene Editing market size will be US$ 3448 million and it is expected to reach US$ 5441.3 million by the end of 2027, with a CAGR of 7.9% during 2021-2027.
This report focuses on the global Gene Editing status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Gene Editing development in North America, Europe, Japan, China, Southeast Asia, India, etc.

Global Gene Editing Scope and Market Size
Gene Editing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Editing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Zinc finger nucleases (ZFNs)
Transcription Activator-Like Effector-based Nucleases (TALENs)
CRISPR-Cas system

Segment by Application
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Contract Research Organizations

By Region
North America
Europe
Japan
China
Southeast Asia
India

By Company
Thermo Fisher Scientific
Merck
Horizo​​n Discovery
Sangamo BioSciences
Integrated DNA Technologies
Lonza
New England Biolabs
OriGene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
CRISPR Therapeutics
RGen Solutions
Sigma-Aldrich
GeneCopoeia
Genscript Biotech